John Thottathil
Chief Tech/Sci/R&D Officer at New River Pharmaceuticals, Inc.
Profile
John K.
Thottathil is a professional who has worked as a Chief Scientific Officer at New River Pharmaceuticals, Inc. since 2006.
Prior to this, he worked as a Director-Core Research & Development Chemistry at Abbott Laboratories and as a Director-Outsourcing, Worldwide Process R & D at Bristol-Myers Squibb World Wide Medicines Group.
He holds a doctorate degree from the Indian Institute of Science.
John Thottathil active positions
Companies | Position | Start |
---|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Chief Tech/Sci/R&D Officer | 2011-04-12 |
Former positions of John Thottathil
Companies | Position | End |
---|---|---|
Bristol-Myers Squibb World Wide Medicines Group
Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The private company is based in Lawrenceville, NJ. | Corporate Officer/Principal | - |
ABBOTT LABORATORIES | Chief Tech/Sci/R&D Officer | - |
Training of John Thottathil
Indian Institute of Science | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Private companies | 2 |
---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
Bristol-Myers Squibb World Wide Medicines Group
Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The private company is based in Lawrenceville, NJ. | Health Technology |
- Stock Market
- Insiders
- John Thottathil